Cargando…

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure

Brain natriuretic peptide (BNP) and its inactive N-terminal fragment, NT-proBNP, are serum biomarkers with key roles in the management of heart failure (HF). An increase in the serum levels of these peptides is closely associated with the pathophysiological mechanisms underlying HF such as the prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alcidi, Gianmarco, Goffredo, Giovanni, Correale, Michele, Brunetti, Natale Daniele, Iacoviello, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181765/ https://www.ncbi.nlm.nih.gov/pubmed/35683578 http://dx.doi.org/10.3390/jcm11113192

Ejemplares similares

Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction
por: Alcidi, Gianmarco, et al.
Publicado: (2023)

Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
por: Tabella, Erika, et al.
Publicado: (2023)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
por: Iacoviello, Massimo, et al.
Publicado: (2022)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)

The Role of Genetics in the Management of Heart Failure Patients
por: Palmieri, Gianpaolo, et al.
Publicado: (2023)

Renal resistance index independently predicts worsening of renal function after coronary angiography
por: Barone, Roberta, et al.
Publicado: (2022)

SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
por: Correale, Michele, et al.
Publicado: (2023)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023)

Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches
por: Correale, Michele, et al.
Publicado: (2021)

Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021)

New Targets in Heart Failure Drug Therapy
por: Correale, Michele, et al.
Publicado: (2021)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

The PONTE (PDTA FOR INTEGRATED FOLLOW-UP TERRITORY HOSPITAL OF THE PATIENT WITH CARDIAC HEART FAILURE) (BRIDGE) Heart Failure project: increased adherence to guideline-recommended therapies through web-based shared clinical database
por: De Gennaro, Luisa, et al.
Publicado: (2022)

Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
por: Angelini, Gianmarco, et al.
Publicado: (2021)

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets
por: Correale, Michele, et al.
Publicado: (2023)

The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
por: Volpe, Massimo, et al.
Publicado: (2015)

Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach
por: Monitillo, Francesco, et al.
Publicado: (2020)

Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
por: Brunetti, Natale Daniele, et al.
Publicado: (2020)

Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2011)

Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
por: Yin, Qiu-Sheng, et al.
Publicado: (2014)

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012)

Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review
por: Gangnus, Tanja, et al.
Publicado: (2019)

Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2020)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure
por: Correale, Michele, et al.
Publicado: (2021)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
por: Fu, Shihui, et al.
Publicado: (2018)

Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
por: Cunha, Filipe M., et al.
Publicado: (2017)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
por: Marinescu, Mihai, et al.
Publicado: (2023)

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
por: Meijers, Wouter C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_95l3rvobbiiashlktgnc94bd8f